Special Issue "Growth Hormone: Therapeutic Possibilities"
Deadline for manuscript submissions: closed (31 December 2017).
Interests: growth hormone
Growth hormone (GH) actions as an endocrine are well established, particularly in post-natal growth and early development; however, its effects are not restricted to the early stages of life. In adults, endocrine GH actions were initially considered to be solely associated with metabolism and homeostasis, but it is now widely accepted that GH is also an important modulator in reproduction, immune function, renal function, neural communication, cognitive processes, and behavior. Recent evidence strongly suggests that GH administration might have positive effects in disease prevention, prognosis, progression and recovery. In different models, in both in vivo and in vitro, GH has demonstrated anti-apoptotic and pro-survival effects, which are involved in neuroprotection, neuro-regeneration, stem cell renewal, cell plasticity and tissue repair. In addition, GH has a pivotal role in oxidative stress, cancer and aging. Contributions to this Special Issue on “Growth Hormone: Therapeutic Possibilities” will provide evidence that justify the future consideration of GH as a possible treatment in different physio-pathologies. The aim of this Special Issue is to emphasize the molecular mechanisms underlying the use of GH in clinical practice.
Prof. Dr. Steve Harvey
Dr. Carlos G. Martinez-Moreno
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
growth hormone (GH)
bone and disease